Episode 252 - Sam Reich - CEO at SAB Bio
From The BioHub - by Avetix · · 25 min
This plays from the publisher's own server. We do not host a copy.
Description
In this episode of The BioHub by Avetix, I’m joined by Sam Reich, CEO of SAB BIO.
Sam shares his unconventional journey from leaving his PhD to build his first biotech, through founding and selling companies, working with influential industry figures like Phil Frost, and eventually leading Big Cypress Acquisition Corp.
We discuss how that journey brought him to SAB BIO, why the company became the right opportunity, the challenges behind its strategic pivot towards type 1 diabetes, and what it takes to keep adapting when the path of a biotech changes.
We also explore the lessons Sam has learned from building, financing and leading companies across multiple stages, and what comes next for SAB as it works to develop a disease-modifying treatment for type 1 diabetes.